Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 345.56M P/E - EPS this Y -2.30% Ern Qtrly Grth -
Income -72.85M Forward P/E -3.85 EPS next Y -17.80% 50D Avg Chg -12.00%
Sales 18.14M PEG - EPS past 5Y - 200D Avg Chg -20.00%
Dividend N/A Price/Book 2.39 EPS next 5Y - 52W High Chg -34.00%
Recommedations 2.00 Quick Ratio 5.68 Shares Outstanding 179.49M 52W Low Chg 12.00%
Insider Own 23.43% ROA -28.70% Shares Float 115.49M Beta 2.04
Inst Own 44.06% ROE -59.99% Shares Shorted/Prior 4.13M/3.69M Price 2.08
Gross Margin - Profit Margin - Avg. Volume 566,532 Target Price 4.40
Oper. Margin -956.64% Earnings Date May 2 Volume 483,415 Change -4.59%
About Arbutus Biopharma Corporation

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.

Arbutus Biopharma Corporation News
03/08/24 Arbutus to Participate in Two Upcoming Investor Conferences
03/03/24 Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
03/02/24 Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue Forecasts
03/01/24 Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
02/29/24 Q4 2023 Arbutus Biopharma Corp Earnings Call
02/29/24 Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
02/29/24 Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials
02/29/24 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
02/15/24 Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
02/02/24 The past three years for Arbutus Biopharma (NASDAQ:ABUS) investors has not been profitable
01/08/24 Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
01/01/24 Institutions own 30% of Arbutus Biopharma Corporation (NASDAQ:ABUS) shares but individual investors control 32% of the company
11/09/23 Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
11/09/23 Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
11/09/23 Arbutus Biopharma Corporation (NASDAQ:ABUS) Q3 2023 Earnings Call Transcript
11/09/23 Analysts Are Betting On Arbutus Biopharma Corporation (NASDAQ:ABUS) With A Big Upgrade This Week
11/08/23 Arbutus to Present at Jefferies London Healthcare Conference
11/08/23 Q3 2023 Arbutus Biopharma Corp Earnings Call
11/07/23 Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
11/07/23 Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
ABUS Chatroom

User Image Shortsales Posted - 36 minutes ago

$ABUS

User Image JRatBullReturns Posted - 12 hours ago

$ABUS damn going arbutus is going to moon soon. I can’t say anything further on this platform legally. Just read the IP lawsuits and connect the dots for yourself. $SPY $RDDT $TSLA $MSFT

User Image jrothman22 Posted - 12 hours ago

$ABUS The day of the results of the Markman Hearing…

User Image LibsRot Posted - 13 hours ago

User Image NoBSPls Posted - 13 hours ago

$ABUS 25 shares AH took us down .12

User Image Buqqets Posted - 15 hours ago

@Ryanmargo so MRNA (and others) can steal IP to barely test/rush 10 injections into people within a 4 year period and then make the taxpayer pay for the entire thing...............AINT THAT AMERICAAAAAAAAAA $ABUS $MRNA

User Image Ryanmargo Posted - 15 hours ago

$ABUS the kicker on the trial is Bidens IP waiver, however, in the case of eminent domain, The fifth amendment requires the government to make the owner of the property whole through compensation. Intellectual property is still property, and that theft, for the nations safety, should be a debt payed to Arbutus if there is a settlement. Total sales to moderna 2021-2024 are over 40 billion, profit margins on the COVID vaccines were supposedly extremely high.

User Image Buqqets Posted - 18 hours ago

$ABUS

User Image renoH4 Posted - 18 hours ago

$ABUS and roivant are very strong today, a real good sign. Imo 90% we will see a settlement or a takeover from an other side.

User Image JAB11131991 Posted - 18 hours ago

$ABUS Looks like Markman victory goes to us. $MRNA PAY UP. Oh and we didn’t forget about you guys either $PFE $BNTX

User Image Blueviking Posted - 19 hours ago

$ABUS Time to settle Moderna!!! !!!!!

User Image Thepatientone Posted - 19 hours ago

$ABUS

User Image Thepatientone Posted - 19 hours ago

$ABUS

User Image anthonydabbraccio Posted - 20 hours ago

$ABUS are there any forego updates

User Image bs010101 Posted - 20 hours ago

$ABUS thank you @ShareholderIncentives :

User Image renoH4 Posted - 20 hours ago

$ABUS.. Who is buying steadyly since weeks? Roivant? What could be the plan.... May be they send the share price down to buy cheap before they make a offer for the rest of the shares, the share price jumps to 10 or 20 $ and they make a big profit.

User Image renoH4 Posted - 21 hours ago

$ABUS.. Someone is buying

User Image NoBSPls Posted - 22 hours ago

$ABUS Here's a hypothetical. Maybe Goldberg would need to recuse himself only if he was going to decide for MRNA. The fact that he hasn't (yet), and self disclosed, could be a positive for ABUS. Of course, in this scenario, MRNA goes nuts with appeals. Either way, appeals are likely. Goldberg must feel he is on solid ground since he stated his Markman decision would come on schedule.

User Image Ryanmargo Posted - 22 hours ago

$ABUS seems as though JD specializes in settlements...

User Image bs010101 Posted - 22 hours ago

$ABUS positive news regarding Moderna's pipeline out daily lately... infringing on any? all? 'if' everything was in jeopardy you'd think they'd try to put us in the rearview mirror or if 'everything' is maybe they're better off trying their 'luck' in the court system who knows.. the right family member could make all the difference lol

User Image YositokoTuqkita Posted - 23 hours ago

$ABUS if a change of Judge is coming, we can see this case being diluted to oblivion. Not shining signs….

User Image DDRPOWER Posted - 1 day ago

$ABUS What a curve ball. This was deliberate from Moderna. Not guaranteed to be beneficial for them, but def raises concerns and lowers confidence in the process. This will force ABUS’ hand. This might require another judge. This will buy time. This wears out plaintifs. What a bad situation for ABUS. Moderna is heavily backed, and they will find ways to corrupt its their way out. Really disappointed.

User Image jrothman22 Posted - 1 day ago

$ABUS Is there a recording available of the hearing today?

User Image EdDwg Posted - 1 day ago

$ABUS Judge is going to need to excuse himself. Plaintiff's legal team must prudently bring it up. So many questions. Has he talked about the case with JD in the past? When did he get hired by Moderna? This should not be too surprising. There's so much history with Arbutus it's like a soap opera. When things start out so tangled and convoluted it plays out the same way to the end. This is not a good development. I had confidence with Goldberg but being completely unbiased is improbable. Now we may need to start over with new judge? Moderna bought time and is undergoing time tested strategy to delay and wear down the plaintiffs. Sigh....Well, maybe we may get to see positive HBV results before we see positive civil action progress or developments.

User Image NoBSPls Posted - 1 day ago

$ABUS Why should this "conflict of interest" bad news. If JD is an M+A lawyer working for MRNA, perhaps they need his expertise to craft a settlement or a takeover??

User Image MrVenndram Posted - 1 day ago

$ABUS Just think if YOUR daughter's h u s b a n d was somehow associated with one of two warring parties involved in a multi-BILLION $,$$$,$$$,$$$ lawsuit... and YOU are the JUDGE Your daughter of the last, I don't know, +-30years, and future +-30years (Would rather vent now, than be really passed if this thing goes sideways!)

User Image Thepatientone Posted - 1 day ago

$ABUS It is Moderna who has enticed US government to file its position on 1498 as an interested party, so ABUS/Genevant have to dig deeper on their communications.

User Image GABIRODZ01 Posted - 1 day ago

$ABUS I don’t like the fact about a potential conflict of interest issue. I don’t believe that ‘JD’ was hired by the M&A firm by coincidence. This is part of an elaborate scheme to invalidate this Markman hearing. Oh boy, I can see this being dragged onto 2026-2027 easily. 😩😩😩

User Image LibsRot Posted - 1 day ago

$ABUS Fingers crossed that Goldberg is not corrupt like so many other judges today. I’m sure Moderna is working hard behind the scenes to pay him off.

User Image Thepatientone Posted - 1 day ago

$ABUS Five witness each and discovery done by June.

Analyst Ratings
Chardan Capital Buy Mar 1, 24
HC Wainwright & Co. Buy Mar 1, 24
HC Wainwright & Co. Buy Sep 12, 23
HC Wainwright & Co. Buy Aug 4, 23
Chardan Capital Buy Aug 4, 23
HC Wainwright & Co. Buy Jul 11, 23
JMP Securities Market Outperform Jul 6, 23
HC Wainwright & Co. Buy Jun 22, 23
Chardan Capital Buy Jun 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sims Karen Chief Medical Office.. Chief Medical Officer Feb 01 Sell 2.31 4,358 10,067 125,542 02/05/24
HASTINGS DAVID C Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 2.31 9,593 22,160 181,907 02/05/24
Sofia Michael J. Chief Scientific Off.. Chief Scientific Officer Feb 01 Sell 2.31 9,982 23,058 1,485,121 02/05/24
McElhaugh Michael J. Interim President &.. Interim President & CEO Feb 01 Sell 2.31 10,164 23,479 1,504,793 02/05/24
McElhaugh Michael J. Chief Business Offic.. Chief Business Officer Dec 16 Sell 5 40,000 200,000 1,327,457 12/16/20